Clinical Trial Update: Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity [NA]

View source ↗

Summary

This clinical trial update describes a study using four-timepoint multi-tracer PET imaging to characterize heterogeneity in metastatic castration-resistant pros…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Snippet

Sponsor: Frederic Pouliot | Conditions: mCRPC (Metastatic Castration-resistant Prostate Cancer) | NA | Status: RECRUITING